Pivot Pharmaceuticals Inc. (PVOTF) Provides Update Covering Recent Achievements and Activities
Update highlights proposed acquisitions, product development and growing IP portfolio Three new patent filings join established global rights to other patented technologies Innovative transdermal delivery technology increases bioavailability of cannabinoids Global cannabis market projected to reach $31.4 billion by 2021 Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) has provided investors an update covering a number of recent achievements and ongoing activities, including the company’s proposed acquisitions of ERS Holdings, LLC and Thrudermic, LLC; its ongoing product development efforts; its growing IP portfolio; its termination of a previously announced standstill agreement; out-licensing of its IP; and its engagement of an established European distribution…